Company Profile

Ultivue Inc
Profile last edited on: 8/23/19      CAGE: 7FZ11      UEI: ZE23LFTC5SV3

Business Identifier: Detection of high number of targets in situ with seamless implementation into existing workflows
Year Founded
2015
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

763D Concord Avenue
Cambridge, MA 02138
   (617) 945-2662
   contact@ultivue.com
   www.ultivue.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Founded by experts in biomolecular analysis, Ultivue is a venture-backed company developing reagent-driven solutions for high-definition biological imaging in situ, combining unlimited multiplexing at high speed with high spatial resolution. With technology licensed from Harvard and from Caltech., Ultivue’s proprietary reagents, instruments, and bioinformatics tools are designed to enable researchers and clinicians to realize the promise of personalized medicine through better matching of patients to therapeutic options. Ultivue's products are designed for fluorescent microscopy-based research judged to be of potentially major value for clinical diagnostic use. The company's patented technologies enable single molecule detection and visualization of a multitude of biomolecules, including proteins and nucleic acids, the key drivers of cellular functions and indicators of disease states

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NIH $299,717
Project Title: Proximity Dna Exchange Imaging

Key People / Management

  Michael Natan -- Chief Executive Officer and President

  Ralf Jungmann -- Co-Founder

  Philippe Mourere -- Senior Vice President of Commercial Operations

  David R Walt -- Co-Founder

  Yifan Yang

  Peng Yin -- Co-Founder

Company News

There are no news available.